LncRNA-HOXB-AS3 peptide suppressed colon cancer (CRC) growth through blocking hnRNPA1-mediated PKM splices, thereby inhibiting the formation of PKM2 and suppressing the reprogramming of the glucose metabolism (Huang et al., 2017). The gene discussed is PKM; the disease is colorectal carcinoma.